GlassScriptPhysician profile
Jacob Starr Duker
NPI 1467807222
$7,907.09
in general payments reported to CMS, 2019-2025
10 companies · $2,966 in 2025
The $2,966 reported for 2025 was more than what 85% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $74.82 · 2021: $494 · 2022: $3,648 · 2023: $329 · 2024: $275 · 2025: $2,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,020 · Food and Beverage: $808 · Travel and Lodging: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,019.50 |
| Food and Beverage | $807.78 |
| Travel and Lodging | $743.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $3,736.74 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $2,861.00 | 2023-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $581.75 | 2021-2024 | Eylea Hd |
| Alimera Sciences, INC. | $274.74 | 2023-2024 | Iluvien, Yutiq |
| Johnson & Johnson Surgical Vision, INC. | $119.83 | 2019 | |
| Bausch & Lomb Americas INC. | $109.95 | 2025 | Xipere |
| Alcon Vision LLC | $74.82 | 2020 | |
| Regeneron Pharmaceuticals, INC. | $56.83 | 2025 | Eylea Hd |
| Eyepoint US, INC. | $54.64 | 2022 | |
| Abbvie INC. | $36.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Duker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.